diphenylamine has been researched along with casein kinase ii in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, Y; Chen, Z; Cheng, H; Friedman, J; Han, J; Kannabiran, V; Mohan, S; VanWaes, C; Zhang, L | 1 |
Chaney, KE; Kendall, JJ; Largaespada, DA; Patel, AV; Ratner, N; Rizvi, TA | 1 |
2 other study(ies) available for diphenylamine and casein kinase ii
Article | Year |
---|---|
MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.
Topics: Animals; Benzamides; Blotting, Western; Casein Kinase II; Cell Line, Tumor; Diphenylamine; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred BALB C; Mice, SCID; Naphthyridines; NF-kappa B; Phenazines; Proto-Oncogene Proteins c-fos; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |
CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; beta Catenin; Casein Kinase II; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Diphenylamine; Drug Synergism; Female; Humans; Mice, Nude; Naphthyridines; Nerve Sheath Neoplasms; Phenazines; Proteolysis; RNA Interference; Xenograft Model Antitumor Assays | 2016 |